Correlation Between Talaris Therapeutics and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Talaris Therapeutics and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Talaris Therapeutics and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Talaris Therapeutics and Aerovate Therapeutics, you can compare the effects of market volatilities on Talaris Therapeutics and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Talaris Therapeutics with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Talaris Therapeutics and Aerovate Therapeutics.
Diversification Opportunities for Talaris Therapeutics and Aerovate Therapeutics
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Talaris and Aerovate is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Talaris Therapeutics and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Talaris Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Talaris Therapeutics are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Talaris Therapeutics i.e., Talaris Therapeutics and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Talaris Therapeutics and Aerovate Therapeutics
Given the investment horizon of 90 days Talaris Therapeutics is expected to under-perform the Aerovate Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Talaris Therapeutics is 2.51 times less risky than Aerovate Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The Aerovate Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 1,702 in Aerovate Therapeutics on August 28, 2024 and sell it today you would lose (1,434) from holding Aerovate Therapeutics or give up 84.25% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 4.24% |
| Values | Daily Returns |
Talaris Therapeutics vs. Aerovate Therapeutics
Performance |
| Timeline |
| Talaris Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Aerovate Therapeutics |
Talaris Therapeutics and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Talaris Therapeutics and Aerovate Therapeutics
The main advantage of trading using opposite Talaris Therapeutics and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Talaris Therapeutics position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.| Talaris Therapeutics vs. Edgewise Therapeutics | Talaris Therapeutics vs. Adicet Bio | Talaris Therapeutics vs. Cullinan Oncology LLC | Talaris Therapeutics vs. Vor Biopharma |
| Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. HCW Biologics | Aerovate Therapeutics vs. Scpharmaceuticals | Aerovate Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |